BriaCell advances melanoma vaccine candidate to genetic engineering milestone
Go back to BriaCell advances melanoma vaccine candidate to genetic engineering milestone| (NASDAQ: BCTX) | Delayed: 3.58 +0.01 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.57 | 52 Week High | $ | |||
| Open | $3.57 | 52 Week Low | $ | |||
| Day High | $3.62 | P/E | N/A | |||
| Day Low | $3.42 | EPS | $ | |||
| Volume | 145,171 | |||||

